Team

PROGENITER is organized for success with a closely knit core team and a layered interaction network that enables synergistic collaboration with adjacent disciplines within the broader expertise of CIEBH teams including social sciences, biomanufacturing, cell therapy and LNP formulation.

Our network is also directly linked to our academic and industrial partners to achieve seamless translation of the discoveries into products, with IP aspects proactively facilitated by the technology transfer offices at The University of British Columbia and Simon Fraser University.

Director

Sriram Subramaniam, Professor, Department of Biochemistry and Molecular Biology, Faculty of Medicine, UBC; Founder and CEO of Gandeeva Therapeutics

Dr. Subramaniam is globally recognized for his leading contributions to cryo-electron microscopy (cryo-EM). He is a Professor, Department of Biochemistry and Molecular Biology, in the Faculty of Medicine at The University of British Columbia, Canada Excellence Research Chair in Precision Cancer Drug Design and Founder and CEO of Gandeeva Therapeutics.

Dr. Subramaniam’s decades-long experience in working with the structural biology of HIV-1, influenza, and Ebola, coupled with his longstanding experience in pioneering development and application of cryo-EM technology, as well as his role in founding Gandeeva Therapeutics and leading its AI-driven cryo-EM platform make him ideally suited to lead all elements of the project.

Website